Resources

Publish Date
Issue Briefs
Drug Competition Enhancement Act
Council for Innovation Promotion
Issue Briefs
Affordable Prescriptions for Patients Act
Council for Innovation Promotion
Government AgendaReports
Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2)
Council for Innovation Promotion
Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: Second Edition
Council for Innovation Promotion
Letters
C4IP Letter to the Office of Science and Technology Policy RE: IP and Innovation
Council for Innovation Promotion
Letters
C4IP Letter to Senators Thom Tillis and Chris Coons RE: PERA and PREVAIL Act
Council for Innovation Promotion
Letters
C4IP Letter to European Commission RE: General Pharmaceutical Legislation and Patent Package
Council for Innovation Promotion
Letters
C4IP Letter to Administration RE: 2022 PTAB Guidance Withdrawal and Interim Guidelines
Council for Innovation Promotion
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on April 3, 2025
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048)
Council for Innovation Promotion
Public Comments
C4IP Written Submission RE: Inv. No. 337-TA-1380
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Development of an Artificial Intelligence (AI) Action Plan (2025-02305)
Council for Innovation Promotion
Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025

Resources:

Resources:

The Congressional Innovation Scorecard: Second Edition,

06/10/2025

Resources:

Resources:

C4IP Letter to the Office of Science and Technology Policy RE: IP and Innovation,

05/09/2025

Resources:

Resources:

C4IP Letter to Senators Thom Tillis and Chris Coons RE: PERA and PREVAIL Act,

05/01/2025

Resources:

Resources:

C4IP Letter to European Commission RE: General Pharmaceutical Legislation and Patent Package,

04/23/2025

Resources:

Resources:

C4IP Letter to Administration RE: 2022 PTAB Guidance Withdrawal and Interim Guidelines,

04/18/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: Hearing on April 3, 2025,

04/02/2025

Resources:

Resources:

C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048),

03/18/2025

Resources:

Resources:

C4IP Written Submission RE: Inv. No. 337-TA-1380,

03/13/2025

Resources:

Resources:

C4IP Comments RE: The Development of an Artificial Intelligence (AI) Action Plan (2025-02305),

03/11/2025

Scroll to Top